Products

All our products are high quality prescription pharmaceuticals used in oncology, as well as niche products administered in a hospital setting. Our main products are:



RESPIKAM®

Composition: Alpha1-Proteinase Inhibitor (Human)
Pharmaceutical form: Solution for infusion
Method of administration: Intravenous (Ready-to-administer)

Therapeutic indication:

Respikam® is an Alpha1 -Proteinase Inhibitor (Human), indicated for chronic augmentation and maintenance therapy in individuals with clinically evident emphysema due to severe hereditary deficiency of Alpha1 -PI, also known as alpha1 -antitrypsin (AAT) deficiency. Respikam® increases antigenic and functional (anti-neutrophil elastase capacity, ANEC) serum levels and antigenic lung epithelial lining fluid levels of Alpha1 -PI.

KamRHO®

Composition: Anti-D Immunoglobulin 150 Mcg/ml
Pharmaceutical form: Solution for injection
Method of administration: Intramuscular

Therapeutic indication:

Pregnancy/other obstetric conditions, Suppression of Rh immunization in non-sensitized Rh0 (D) negative women delivering an Rh positive baby or when the baby’s Rh type is unknown. Suppression of Rh immunization after spontaneous or induced abortions threatened abortion associated with maternal bleeding amniocentesis chorionic villus sampling ruptured tubal pregnancy and significant abdominal trauma. Kam Rh0 -D IM should be given within 72 hours of the event. It may be given even after up to one month although efficacy may be somewhat reduced. Transfusion: Suppression of Rh isoimmunization in Rh0 (D) antigen-negative patients transfused with Rh0 (D) antigen-positive RBCs of blood components containing Rh0 (D) antigen-positive RBCs. Initiate treatment within 72 hours of exposure.

REBINOLIN®

Composition: Human-rabies immunoglobulin 150 IU/ml
Pharmaceutical form: Solution for injection
Method of administration: Intramuscular

Therapeutic indication:

Rebinolin® is indicated for passive, transient post-exposure prevention of rabies infection when given immediately to individuals in cases of contact with rabid or possibly rabid animal. This product is used in persons with any injuries of the skin, including bites, wounds and scratches caused by wild or domestic animals with rabies, as well as in those cases when the saliva of infected animals contacts with mucous membranes or injured skin.

NexoBrid®

Composition: Bromelain
Pharmaceutical form: Lyophilized powder and gel vehicle
Method of administration: Cutaneous use

Therapeutic indication:

NexoBrid™, was approved in December 2012 by EMA via a centralized procedure and was granted orphan indication for removal of eschar (also known as debridement) in adults with deep partial- and full-thickness thermal burns .



Vasomirin

Composition: Desmopressin
Pharmaceutical form: Nasal spray

Therapeutic indication:

Desmopressin nasal spray is indicated as antidiuretic replacement therapy in the management of central cranial diabetes insipidus and for management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region. It is ineffective for the treatment of nephrogenic diabetes insipidusDesmopressin nasal spray is indicated as antidiuretic replacement therapy in the management of central cranial diabetes insipidus and for management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region. It is ineffective for the treatment of nephrogenic diabetes insipidus"..



TOBRAMYCIN-GOBBI

Composition: Tobramycin
Pharmaceutical form: Solution for inhalations, in ampoules
Method of administration: By inhalation

Therapeutic indication:

Tobramycin Inhalation Solution is a prescription medicine that is used to treat people with cystic fibrosis who have a bacterial infection called Pseudomonas aeruginosa. Tobramycin Inhalation Solution contains an antibacterial medicine called tobramycin (an aminoglycoside).